Cargando…

Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models

BACKGROUND: Although genotypic resistance testing (GRT) is recommended to guide combination antiretroviral therapy (cART), funding and/or facilities to perform GRT may not be available in low to middle income countries. Since treatment history (TH) impacts response to subsequent therapy, we investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prosperi, Mattia C. F., Rosen-Zvi, Michal, Altmann, André, Zazzi, Maurizio, Di Giambenedetto, Simona, Kaiser, Rolf, Schülter, Eugen, Struck, Daniel, Sloot, Peter, van de Vijver, David A., Vandamme, Anne-Mieke, Sönnerborg, Anders
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966424/ https://www.ncbi.nlm.nih.gov/pubmed/21060792 http://dx.doi.org/10.1371/journal.pone.0013753

Ejemplares similares

Correction: Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models
por: Prosperi, Mattia C. F., et al.
Publicado: (2011)

Selecting anti-HIV therapies based on a variety of genomic and clinical factors
por: Rosen-Zvi, Michal, et al.
Publicado: (2008)

Comparison of Classifier Fusion Methods for Predicting Response to Anti HIV-1 Therapy
por: Altmann, André, et al.
Publicado: (2008)

The EuResist expert model for customised HAART optimisation: 2010 update and extension to newest compounds
por: Pironti, A, et al.
Publicado: (2010)

Time on drug analysis based on real life data
por: Schülter, Eugen, et al.
Publicado: (2014)

Clinical use, efficacy, and durability of maraviroc for antiretroviral therapy in routine care: A European survey
por: De Luca, Andrea, et al.
Publicado: (2019)

Superinfection with drug-resistant HIV is rare and does not contribute substantially to therapy failure in a large European cohort
por: Bartha, István, et al.
Publicado: (2013)

Clinical Evaluation of Rega 8: An Updated Genotypic Interpretation System That Significantly Predicts HIV-Therapy Response
por: Vercauteren, Jurgen, et al.
Publicado: (2013)

Only Slight Impact of Predicted Replicative Capacity for Therapy Response Prediction
por: Weisser, Hendrik, et al.
Publicado: (2010)

Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping
por: Prosperi, Mattia CF, et al.
Publicado: (2010)

Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time
por: Frentz, Dineke, et al.
Publicado: (2010)

Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors
por: De Luca, Andrea, et al.
Publicado: (2015)

A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen
por: Prosperi, Mattia CF, et al.
Publicado: (2011)

The global burden of HIV-1 drug resistance in the past 20 years
por: Zazzi, Maurizio, et al.
Publicado: (2018)

Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy
por: Svärd, Jenny, et al.
Publicado: (2017)

HIV-1 mutational pathways under multidrug therapy
por: Lawyer, Glenn, et al.
Publicado: (2011)

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study
por: Prosperi, Mattia CF, et al.
Publicado: (2012)

Pre‐existing singleton E138A mutations in the reverse transcriptase gene do not affect the efficacy of first‐line antiretroviral therapy regimens using rilpivirine in human immunodeficiency virus‐infected patients
por: Kuznetsova, Anna, et al.
Publicado: (2022)

Cohort Profile: A European Multidisciplinary Network for the Fight against HIV Drug Resistance (EuResist Network)
por: Rossetti, Barbara, et al.
Publicado: (2023)

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients
por: Fabbiani, Massimiliano, et al.
Publicado: (2014)

Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype
por: Salvo, Pierluigi Francesco, et al.
Publicado: (2023)

Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort
por: Elvstam, Olof, et al.
Publicado: (2022)

Using drug exposure for predicting drug resistance – A data-driven genotypic interpretation tool
por: Pironti, Alejandro, et al.
Publicado: (2017)

The Health Gym: synthetic health-related datasets for the development of reinforcement learning algorithms
por: Kuo, Nicholas I-Hsien, et al.
Publicado: (2022)

Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes
por: Rhee, Soo-Yon, et al.
Publicado: (2012)

Increasing risk behaviour can outweigh the benefits of antiretroviral drug treatment on the HIV incidence among men-having-sex-with-men in Amsterdam
por: Mei, Shan, et al.
Publicado: (2011)

Dried blood spot testing: filling the gap between antiretroviral treatment & monitoring in India
por: Zazzi, M.
Publicado: (2012)

Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study
por: Gagliardini, Roberta, et al.
Publicado: (2018)

Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium
por: Vinken, Lore, et al.
Publicado: (2019)

The Threshold Bootstrap Clustering: A New Approach to Find Families or Transmission Clusters within Molecular Quasispecies
por: Prosperi, Mattia C. F., et al.
Publicado: (2010)

Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice
por: Borghetti, Alberto, et al.
Publicado: (2021)

A novel methodology for large-scale phylogeny partition
por: Prosperi, Mattia C.F., et al.
Publicado: (2011)

Single-tablet regimen is associated with reduced efavirenz withdrawal in antiretroviral naïve or switching for simplification HIV-infected patients
por: Fabbiani, M, et al.
Publicado: (2012)

Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study
por: Bavaro, Davide F., et al.
Publicado: (2022)

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
por: Bianco, Claudia, et al.
Publicado: (2014)

Optimised paediatric antiretroviral treatment to achieve the 95-95-95 goals
por: Archary, Moherndran, et al.
Publicado: (2021)

Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings
por: Sangeda, Raphael Z, et al.
Publicado: (2014)

Predictors of non adherence to antiretroviral therapy at an urban HIV care and treatment center in Tanzania
por: Sangeda, Raphael Z, et al.
Publicado: (2018)

PhyloGeoTool: interactively exploring large phylogenies in an epidemiological context
por: Libin, Pieter, et al.
Publicado: (2017)

Combining Epidemiological and Genetic Networks Signifies the Importance of Early Treatment in HIV-1 Transmission
por: Zarrabi, Narges, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gd5sknfg5pgs2nhfe43fda5aum